Franklin Genomic Advancements ETF · $36M$8,473
HELXHELX vsVHTVHTVanguard Health Care ETF · $19.1B$14,313
$10,000 five years ago, dividends reinvested · they hold 14.1% in common
HELXMeasureVHT
Returns · dividends reinvested
+22.4%Year to dateJan 1 → Nov 3+19.6%
+26.6%1 yearTotal return+28.1%
+20.5%3 years · per year$10,000 became $17,514 · $15,988+16.9%
−3.3%5 years · per year$10,000 became $8,473 · $14,313+7.4%
Cost and income
0.50%Expense ratio$50 · $9 a year on $10k · lower is better0.09%
0.32%Trailing 12-mo yield$32 · $135 a year on $10k1.35%
Risk · past year
−18.0%Worst dropSmaller is better−10.4%
24.6%VolatilityLower is calmer15.8%
HELXVHT Winner of the row, in its colourEach row: the bigger of the two fills its side
2–6VHT wins
End-of-day Nov 3, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns